Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03560037 · ClinicalTrials.gov registry record · NA
Use of a Distal Colonoscope Attachment to Increase Detection of Sessile Serrated Adenomas
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 427
- Enrollment target
NCT03560037: Completed NA study, sponsored by University of California, Davis.
NCT03560037 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 427 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03560037, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 427 participants
- Enrollment target
Study Summary
This study evaluates whether the use of a disposable colonoscope attachment, Endocuff Vision, can increase the detection of sessile serrated adenomas. Participating patients will be randomized to receive either standard colonoscopy or colonoscopy with the Endocuff Vision.
Primary Outcome
Number of colonoscopies with at least one sessile serrated adenoma
Interventions
- DEVICE Endocuff Vision Assisted Colonoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 427 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2023-12-05 |
| Phase | NA |
What the finished NCT03560037 record still lists
NCT03560037 is an interventional study that assigns participants to a tested intervention. The registered 427 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 1 intervention - of which Endocuff Vision Assisted Colonoscopy is the first listed.
NCT03560037 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03560037 about?
NCT03560037 is a clinical study titled "Use of a Distal Colonoscope Attachment to Increase Detection of Sessile Serrated Adenomas". This study evaluates whether the use of a disposable colonoscope attachment, Endocuff Vision, can increase the detection of sessile serrated adenomas. Participating patients will be randomized to receive either standard colonoscopy or colonoscopy with the Endocuff Vision.
What is the current status of trial NCT03560037?
This trial is currently completed. It is a NA study. The enrollment target is 427 participants. The study started on 2019-05-01. Estimated completion is 2023-12-05.
What interventions are being tested in trial NCT03560037?
The interventions under investigation include: Endocuff Vision Assisted Colonoscopy (DEVICE).
Who is sponsoring clinical trial NCT03560037?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03560037's enrollment target sits among peer trials
427 236th of 2000 higher than 1,765 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05566431 · 428 participants · NA
Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics
- NCT05646316 · 428 participants · Phase 3
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
- NCT05797610 · 428 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
- NCT06073626 · 428 participants · NA
Addressing Genomic Disparities in Cancer Survivors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI